Digest Network Come funziona
Network
/
Società
In
Non verificato

Innoviva Specialty Therapeutics

Di cosa scriviamo

FarmaceuticaHIV, AIDS e malattie autoimmuniIndustriaMedicina - VarieSalute

3 comunicati stampa

Guarda tutti i comunicati
10/03/2026
Industria
Salute
HIV, AIDS e malattie autoimmuni
Sanità
Medicina - Varie
Farmaceutica
Biotecnologia
Innoviva Specialty Therapeutics Earns Strong Performance Rating in Access to Medicine Foundation’s 2026 Antimicrobial Resistance Benchmark Report
Fonte
Innoviva Specialty Therapeutics
Emittente
Business Wire
1.00
0
20/10/2025
Biotecnologia
Sanità
HIV, AIDS e malattie autoimmuni
Salute
Farmaceutica
Eventi
Fiere
Industria
Innoviva Specialty Therapeutics Announces Oral Presentation Featuring New Analyses from the Zoliflodacin Pivotal Phase 3 Trial at IDWeek 2025
Fonte
Innoviva Specialty Therapeutics
Emittente
Business Wire
1.00
0
07/10/2025
Salute
HIV, AIDS e malattie autoimmuni
Medicina - Varie
Scienza
Farmaceutica
Eventi
Industria
Innoviva Specialty Therapeutics to Deliver Six Presentations from its Infectious Diseases and Critical Care Portfolio at IDWeek 2025
Fonte
Innoviva Specialty Therapeutics
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0